Skinny-Label Biosimilars Provide Substantial Savings to Medicare
The estimated savings to Medicare during 2015-2020 that resulted from competition with five of the first-to-market biosimilars with skinny labels was $1.5 billion.
Stay updated with breaking news from Iv Im. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The estimated savings to Medicare during 2015-2020 that resulted from competition with five of the first-to-market biosimilars with skinny labels was $1.5 billion.
At's cd,corrt. i the trianva is n omp'ste.rr as i endetandva asout nmp. 5% oas thde ndate s a betover. o th e ibe berievebout 70will e b ve verebyut torro70lle m si in re bk an t waroing fo th ca ass si ban coaleteg fothas >> reta coteabou sve >> taght urs o the wasou s big ange t s th eyou as 40.ig ge u up40 vtes. u 4 yohad beehin up yeerda vs. abou yo d0 andbeome chaine.yeda en t ou bckbuer neane toy.ha i wched t the bbureseonfence to i w ed he ukeses cfeuntyestunng news not esooksike u cty areun ws nokse u overre 750 er ves?50 thas v mynderandi, in ha waeshay cotyerdi morinthan -- waha co t...